Gynecologic imaging
Introduction Gynecologic malignancies are a considerable source of morbidity and mortality, accounting for nearly 672,000 deaths globally in 2020 ( ). Imaging complements surgical and clinical gynecologic cancer staging. Pelvic…
Introduction Gynecologic malignancies are a considerable source of morbidity and mortality, accounting for nearly 672,000 deaths globally in 2020 ( ). Imaging complements surgical and clinical gynecologic cancer staging. Pelvic…
Introduction The use of positron emission tomography (PET) in the evaluation of genitourinary malignancies has traditionally been hampered by low tumor uptake and the masquerading effect of excreted radiopharmaceutical activity…
Introduction Positron emission tomography/magnetic resonance imaging (PET/MRI) is an innovative imaging technology that simultaneously acquires PET and MRI, allowing the integration of sensitive metabolic and functional information with precise structural…
Acknowledgments Funding was provided in part by the 2020–Research and Innovation Framework Program PHC-11-2015 Nr. 667211, Jubiläumsfonds of the Austrian National Bank # Nr: 18207and seed grants from Novomed Austria…
Primary bone and soft tissue malignancies Primary bone and soft tissue malignancies are a heterogeneous group of relatively rare tumors, most of them deriving from mesenchymal tissue (sarcomas). The reported…
Introduction Blood malignancies account for approximately 10% of newly diagnosed malignant tumors in the United States. While a large number of different blood cancer entities exist, three main groups are…
Acknowledgments This work was in part supported by a grant from the National Cancer Institute, grant number R01CA269231, and the Sarcoma Foundation of America. We thank Mehdi Khalighi, Dawn Holley,…
Acknowledgments We would like to thank Sabine Frank, Susan Notohamiprodjo and Alberto Villagran for their assistance preparing this chapter. Introduction In recent years, numerous imaging modalities have been developed to…
Acknowledgments VG has received funding from the Swiss National Science Foundation (project n. 185028, 188355 and 169876), the Velux Foundation, the Schmidheiny Foundation and research/teaching support through her institution from…
Clinical management of malignancies of the chest Lung cancer Lung cancer is the leading cause of cancer deaths in men and women worldwide with a 5-year survival of only around…